Genus’ (GNS) “Buy” Rating Reaffirmed at Peel Hunt Posted by Joseph Griffin
Peel Hunt reissued their buy rating on shares of Genus (LON:GNS) in a research note issued to investors on Tuesday morning, ThisIsMoney.Co.Uk reports.
Several other analysts have also recently issued reports on the stock. Liberum Capital upgraded shares of Genus to a buy rating and upped their target price for the company from GBX 2,400 ($31.36) to GBX 2,500 ($32.67) in a research report on Tuesday, March 5th. HSBC initiated coverage on shares of Genus in a research report on Tuesday, February 12th. They set a buy rating and a GBX 2,650 ($34.63) target price on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Genus presently has a consensus rating of Buy and a consensus target price of GBX 2,743 ($35.84). Get Genus alerts:
Shares of LON GNS opened at GBX 2,660 ($34.76) on Tuesday. The company has a debt-to-equity ratio of 22.58, a quick ratio of 1.32 and a current ratio of 2.08. The stock has a market cap of $1.71 billion and a PE ratio of -246.30. Genus has a 12-month low of GBX 2,090 ($27.31) and a 12-month high of GBX 2,998 ($39.17). About Genus
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.